Clinical Trial Update: Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM) [NA]

View source ↗

Summary

Liom Health AG's non-invasive continuous glucose monitor (niCGM) trial NCT06272136 is currently recruiting. The study targets individuals with Type 1 diabetes a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Liom Health AG | Conditions: Type 1 Diabetes, Type2diabetes | NA | Status: RECRUITING